IconicAlpha
← Back to the wall
Merck & Co Inc

Merck & Co Inc

MRK · Healthcare · Pharmaceuticals

Market cap
$325.57B
Price
$131.11
Daily change
-0.54%
Rank
#35

Updated 25 min ago · data delayed ≥15 min

Iconic Score

Proprietary
68/ 100
Scale68
Momentum47
Sector leadership93

Ranked #33 of 503 by Iconic Score · #5 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a blend of scale, market attention, and category leadership.

Iconic Profile

Merck & Co Inc (MRK) is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. With a market capitalization of $305.1 billion, Merck is recognized for its innovative research and development, particularly in oncology, infectious diseases, and vaccines, including its well-known HPV vaccine, Gardasil, and the blockbuster cancer treatment, Keytruda. The company maintains a strong market position, leveraging a robust pipeline of new therapies and a commitment to addressing unmet medical needs. Merck's focus on scientific advancement and strategic partnerships enhances its competitive edge in the pharmaceutical sector, making it a significant player in improving global health outcomes. Its ongoing efforts in sustainability and access to medicines further underscore its importance in the healthcare landscape.

Visit website ↗Compare ⇄Claim this profile

Enterprise tier: claim your logo to manage how your brand is represented.